Regorafenib will be the Only Approved Agent in the Second Line - 101341

Spotlight
Video

Regorafenib will be the Only Approved Agent in the Second Line

obr has 439 videos Subscribe Here

Loading........
Description: Thomas A. Abrams, MD of Dana Farber Cancer Institute discusses regorafenib in clinical practice at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.
Shared By : obr
Posted on : 01/25/17
Added : 2 years ago